Medtronic grows, but not as much as expected
This article was originally published in Clinica
Analysts were disappointed by Medtronic on November 17 when the company reported second-quarter net earnings of $536m, against a Thomson First Call analyst consensus projection of $553m. Nevertheless, the profit was up by 13%, on an 11% revenue increase to $2.4bn.
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.